Updated: May 15, 2023

This NABH-Covid-19 Resources page is designed to help NABH members access important and applicable resources as they navigate the Covid-19 pandemic. The first section includes PDF documents from NABH and other organizations, and the second section includes links to federal guidance and other applicable information from federal agencies and non-government organizations.

Thank you for the excellent care you and your teams continue to provide during this difficult time. Please write to us with concerns or questions at nabh@nabh.org.

Latest Resources

Archived Documents

3-9-21: CMS Covid-19 Vaccine Policies & Guidance

2-5-2021: Joint Commission Sentinel Alert: Pandemic Special Edition, Part 1

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

1-29-21: CMS Issues Memo Clarifying Hospital Survey Expectations During Pandemic

1-18-21: HHS Updates PRF Reporting Requirements

12-18-20: Letter to Sec. Azar on Access to Covid-19 Vaccine for Mental Health and Addiction Treatment Providers and Consumers

12-11-20: HHS Covid-19 Guidance for Hospital Reporting and FAQs for Hospitals, Hospital Laboratory, and Acute Care Facility Data Reporting

12-3-20: NABH Letter to NGA on Covid-19 Vaccine Distribution

11-20-20: NABH Participates in NQF Webinar

10-23-20: General and Targeted Distribution Post-Payment Notice of Reporting Requirements

10-17-20: CMS Infographic on Covid-19 Data Reporting

10-17-20: CMS Guidance on Covid-19 Data Reporting

9-21-20: CDC Updates COVID-19 Testing Guidance

9-8-20: NABH Letter on Covid-19 Reporting Requirements

9-3-20: HHS Updated Covid-19 Workforce Virtual Toolkit

8-13-20: HHS Provider Relief Fund Webinar Presentation

8-13-20: Provider Relief Fund Step-by-Step Provider Guide

8-13-20: Provider Relief Fund Stakeholder Toolkit

  • 7-26-20: Updated CDC Guidelines on Infection Control in Psychiatric Hospitals

7-14-20: Covid-19 Guidance and FAQ for for Hospital Reporting

6-25-20: HHS Issues New FAQs on Emergency Relief Fund Reporting

6-15-20: CDC Releases Guidance on Telehealth Benefits, Strategies and Safeguards

6-5-20: CoP letter to Seema Verma

5-29-20: COVID-19 Frequently Asked Questions (FAQs) on Medicare Fee-for-Service (FFS) Billing

5-26-20: Center for Connected Health Policy: Telehealth Policy in a Post-Covid-19 World

5-26-20: HHS Announces 45-Day Compliance Deadline Extension for Providers

5-18-20: SAMHSA Guidance on Covid-19 and Health Disparities

5-18-20: CMS Outlines Medicaid Managed Care Options in Responding to Covid-19

5-18-20: Tricare Interim Final Rule (Telehealth)

5-12-20: NABH Covid-19 Task Force Letter to Congress

5-11-20: CMS Provides Summary of Recent Actions

Provider Relief Fund (PFR)

1-1-22: HRSA Fact Sheet on Provider Relief Fund Reporting Period 2 (RP2)

9-15-21: HHS Announces the Availability of $25.5 Billion in COVID-19 Provider Funding

9-15-21: Provider Relief Fund Phase 3: Payment Calculation Methodology

9-15-21: Information on the application process and eligibility requirements

9-15-21: PRF Reporting Requirements

CARES Act

  • 4-17-20: HHS’ CARES Act Provider Relief Fund Portal
  • 4-6-20: AHA Urges SBA to Ensure Hospitals Can Participate in CARES Act Loan Program
  • 4-3-20: Holland & Knight Healthcare Blog on Covid-19 Funding for Healthcare Providers

CDC

  • 9-21-20: CDC Updates COVID-19 Testing Guidance
  • CDC Guidance for Healthcare Providers

Staffing

  • 7-14-21: NurseJournal article on Combatting Compassion Fatigue
  • 9-3-20: HHS Updated Covid-19 Workforce Virtual Toolkit
  • 7-14-20: 59 Mental Health Resources for Health Care Providers
  • CMS Medicare Provider Enrollment Relief FAQs
  • CMS 1135 Waiver Checklist Template CMS Guidance 1135

Addiction

SAMHSA:

National Academy for State Health Policy

  • 5-19-20: State Actions to Strengthen Workforce Capacity to Address OUD during COVID-19
  • State Strategies for OUD Treatment During Covid-19 Pandemic

HHS Office for Civil Rights

American Society of Addiction Medicine

ASAM Covid-19 Resources (4-2-20)

Motivational Incentives Policy Group

Letter to Sec. Alex Azar on implementation of Motivational Incentives

Infection Control

  • 7-26-20: Updated CDC Guidelines on Infection Control in Psychiatric Hospitals
  • 4-9-20: CMS Updated Guidance on Infection Control for ICF/IID & PRTF
  • 4-9-20: CMS Updated Guidance on Infection Control for Hospitals
  • CMS Infection Control Guidance for Outpatient Settings
  • The Joint Commission’s Covid-19 Infection Control Guidance
  • National Institute of Environmental Health Sciences Resources

Personal Protective Equipment (PPE)

CMS

  • 5-20-20: CMS Updated Guidance on Emergency Declaration Blanket Waivers for Health Care Providers
  • 5-6-20: CMS Releases Updated FAQs
  • CMS Announces Relief for Quality Reporting Programs
  • CMS Guidance for Healthcare Providers
  • CMS Virtual Toolkit
  • CMS Guidance on section 1135 authority that allows waiver of certain Medicare, Medicaid, and Children’s Health Insurance Program (CHIP) requirements

EMTALA

  • CMS Covid-19 and EMTALA Memo
  • CMS Guidance on 1135 Waiver Authority

Telehealth

  • 8-13-20: Manatt Research on Telehealth Coverage After Public Health Emergency
  • 5-7-20: Brookings Publishes Report on Removing Regulatory Barriers to Telehealth
  • 5-5-20: AHRQ Releases Guidance for Obtaining Consent for Telehealth
  • 4-23-23: CMS State Medicaid and CHIP Telehealth Toolkit
  • 4-2-20: DEA and SAMSHA Release Guidance on Buprenorphine and Telemedicine
  • 3-24-20: CMS Telehealth March 24 FAQs
  • CMS 2020 Telehealth Services Booklet
  • Telehealth Coverage Policies Summary from the Center for Connected Health Policy
  • CMS Guidance and FAQs on Telehealth in Medicare
  • CMS Guidance on Telehealth in Medicaid
  • HHS Office of Inspector General (OIG) Policy Statement and Fact Sheet on Telehealth Cost-Sharing
  • HHS Office for Civil Rights Guidance on Waiver of HIPAA Sanctions and Penalties Related to Telehealth
  • Drug Enforcement Administration Guidance on Telemedicine and Medication-Assisted Treatment

State Policies

  • State Strategies for OUD Treatment During Covid-19 Pandemic
  • National Governors Association Covid-19 Updates
  • Kaiser Family Foundation Medicaid Emergency Authority Tracker

Other

  • 4-17-20: NIMH Shareable Resources on Coping with Covid-19
  • 4-15-20: Manatt’s Overview of FEMA Public Assistance Program Funding for Covid-19
  • 4-6-20: OIG Statement on Administrative Enforcement Authorities due to Covid-19 Emergency
  • Updated 4-2-20: U.S. Labor Department’s FAQs on the Families First Coronavirus Response Act 
  • HHS’ Office of Inspector General released a COVID-19 Fraud Alert with general information
  • HHS Office of Inspector General’s Covid-19 Portal
  • The Joint Commission’s Webinar on Preparing Behavioral Health Organizations for Covid-19
  • HRSA Covid-19 Funding, Resources, and Oversight FAQs
  • HRSA Technical Assistance for Award Recipients

NABH Covid-19 Task Force

NABH’s Covid-19 Task Force works with the NABH team in Washington to identify the most challenging issues facing U.S. behavioral healthcare providers during the Covid-19 pandemic. The task force will also develop recommendations that NABH will share with relevant federal agencies, congressional offices, and the general public.

  • Pat Connell, R.N., M.B.A., F.A.C.H.E., C.B.H.E., C.H.C., Boys Town Behavioral Health Division
  • Michael Genovese, M.D., J.D., Acadia Healthcare, Inc.
  • Frank A. Ghinassi, Ph.D., A.B.P.P., Rutgers University Behavioral Health Care/RWJBarnabas Health
  • Karen Johnson, M.S.W., Universal Health Services, Inc.
  • Gail Ryder, M.S., BayCare Behavioral Health
  • Mark Schneider, Vizion Health, LLC
  • Harsh K. Trivedi, M.D., M.B.A., Sheppard Pratt
  • Rochelle Archuleta, Co-Staff Liaison, National Association for Behavioral Healthcare
  • Shawn Coughlin, Co-Staff Liaison,  National Association for Behavioral Healthcare